propranolol has been researched along with Ehlers-Danlos Syndrome in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sebastián-Ochoa, A | 1 |
Quesada-Charneco, M | 1 |
Fernández-García, D | 1 |
Reyes-García, R | 1 |
Rozas-Moreno, P | 1 |
Escobar-Jiménez, F | 1 |
1 other study available for propranolol and Ehlers-Danlos Syndrome
Article | Year |
---|---|
Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.
Topics: Adult; Antithyroid Agents; Cholestyramine Resin; Drug Resistance; Drug Therapy, Combination; Ehlers- | 2008 |